The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors

Baur, R; Gertsch, J; Sigel, E (2012). The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABA(A) receptors. British journal of pharmacology, 165(8), pp. 2479-84. Oxford: Wiley-Blackwell 10.1111/j.1476-5381.2011.01405.x

Full text not available from this repository. (Request a copy)

Rimonabant (SR141716) and the structurally related AM251 are widely used in pharmacological experiments as selective cannabinoid receptor CB(1) antagonists / inverse agonists. Concentrations of 0.5-10 µM are usually applied in in vitro experiments. We intended to show that these drugs did not act at GABA(A) receptors but found a significant positive allosteric modulation instead.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Biochemistry and Molecular Medicine

UniBE Contributor:

Baur, Roland; Gertsch, Jürg and Sigel, Erwin

ISSN:

0007-1188

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:37

Last Modified:

06 Dec 2013 13:37

Publisher DOI:

10.1111/j.1476-5381.2011.01405.x

PubMed ID:

21470203

Web of Science ID:

000301925200008

URI:

https://boris.unibe.ch/id/eprint/15043 (FactScience: 222197)

Actions (login required)

Edit item Edit item
Provide Feedback